Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...
A new study has found that specific regions of the brain are activated after a drug is taken intravenously but not when the same drug is taken orally, with increased activity correlating to an ...
If approved, the monthly IV maintenance regimen is expected to maintain the effectiveness of the treatment while being less burdensome for patients. The Food and Drug Administration (FDA) has accepted ...
A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to optimize the capacity of drug-delivery into these cells. The team was led ...
As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.